We’re celebrating two incredible milestones in New York today. It marks 20 years since AtriCure became a publicly traded company on the Nasdaq (ATRC) and 25 years since our founding.​ From a small, passionate team in 2000 to a global presence today, we’ve expanded treatment options for Afib, cardiac surgery, and post-operative pain—all while keeping patients at the heart of everything we do.​

Through two decades of clinical trials, research and innovation, we’ve helped treat over 1 million patients, and we’re just getting started.​

<a href='https://www.linkedin.com/feed/hashtag/?keywords=Nasdaqlisted&highlighte…; target='_blank'>#Nasdaqlisted</a> <a href='https://www.linkedin.com/feed/hashtag/?keywords=AllWaysInnovating&highl…; target='_blank'>#AllWaysInnovating</a>